HRH1, an NSCLC survival hazard gene found in this study, was underexpressed in NSCLC tumor B cells and was associated with resistance to erlotinib and vinorelbine in human NSCLC epithelial cell lines. The gene discussed is HRH1; the disease is neoplasm.